Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000950170-24-062052

Chief Legal Officer and EVP sold 843 shares at $0.94 ($792)

  • Chief Legal Officer and EVP acquired 2,656 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

DesRosier Thomas · Chief Legal Officer and EVP

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-15 Exercise or conversion : show line 1 in the form 10b5-1 +2,656 123,233 D
2024-05-15 Sale : show line 2 in the form 10b5-1 −843 $0.94 $792 122,390 D
Open-market sales · 843 sh · avg $0.94 · $792

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-15 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units −2,656 29,219 D
Loading xslF345X05/ownership.xml…